Brendani B - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Effects of Therapeutic and Supratherapeutic Doses of Siponimod (BAF312) on Cardiac Repolarization in Healthy Subjects.

Shakeri-Nejad K, Aslanis V, Veldandi UK, Mooney L, Pezous N, Brendani B, Juan A, Allison M, Perry R, Legangneux E. Shakeri-Nejad K, et al. Among authors: brendani b. Clin Ther. 2015 Nov 1;37(11):2489-2505.e2. doi: 10.1016/j.clinthera.2015.09.006. Epub 2015 Oct 27. Clin Ther. 2015. PMID: 26519230 Clinical Trial.

Cardiac Effects of Siponimod (BAF312) Re-initiation After Variable Periods of Drug Discontinuation in Healthy Subjects.

Legangneux E, Shakeri-Nejad K, Aslanis V, Sagkriotis A, Pezous N, Brendani B, Behrje R, Gutierrez M. Legangneux E, et al. Among authors: brendani b. Clin Ther. 2016 Mar;38(3):631-45.e1. doi: 10.1016/j.clinthera.2016.01.021. Epub 2016 Feb 23. Clin Ther. 2016. PMID: 26916566 Clinical Trial.

Identification of Substandard Medicines via Disproportionality Analysis of Individual Case Safety Reports.

Trippe ZA, Brendani B, Meier C, Lewis D. Trippe ZA, et al. Among authors: brendani b. Drug Saf. 2017 Apr;40(4):293-303. doi: 10.1007/s40264-016-0499-5. Drug Saf. 2017. PMID: 28130773

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters